Time for a new paradigm shift in myocardial infarction
Yıl: 2021 Cilt: 25 Sayı: 3 Sayfa Aralığı: 156 - 162 Metin Dili: İngilizce DOI: 10.5152/AnatolJCardiol.2021.89304 İndeks Tarihi: 23-05-2022
Time for a new paradigm shift in myocardial infarction
Öz: The ST-elevation myocardial infarction (STEMI)/non-STEMI paradigm per the current guidelines has important limitations. It misses a substantial proportion of acute coronary occlusions (ACO) and results in a significant amount of unnecessary catheterization laboratory activations. It is not widely appreciated how poor is the evidence base for the STEMI criteria; the recommended STEMI cutoffs were not derived by comparing those with ACO with those without and not specifically designed for distinguishing patients who would benefit from emergency reperfusion. This review aimed to discuss the origins, evidence base, and limitations of STEMI/non-STEMI paradigm and to call for a new paradigm shift to the occlusion MI (OMI)/non-OMI.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
- 1. Weigert C. Ueber die pathologiische Gerinnugs-Vorgange. Arch Path Anat (Virchow) 1880; 79: 87-123. [Crossref]
- 2. Herrick JB. Clinical features of sudden obstruction of the coronary arteries. JAMA 1912; 23: 2015-22. [Crossref]
- 3. Pardee HEB. An electrocardiographic sign of coronary artery obstruction. Arch Intern Med 1920; 26: 244-57.[Crossref]
- 4. Sherry S. Personal reflections on the development of thrombolytic therapy and its application to acute coronary thrombosis. Am Heart J 1981; 102: 1134-8. [Crossref] 5. Rentrop KP, Blanke H, Karsch KR, Wiegand V, Köstering H, Oster H, et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2: 354-63. [Crossref]
- 6. Streptokinase in acute myocardial infarction. European Cooperative Study Group for Streptokinase Treatment in Acute Myocardial Infarction. N Engl J Med 1979; 301: 797-802. [Crossref]
- 7. DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303: 897-902. [Crossref]
- 8. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1986; 1: 397-402.
- 9. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-428.
- 10. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994; 343: 311-22. [Crossref]
- 11. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34: 890-911. [Crossref]
- 12. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). Circulation 2000; 102: 1193-209. [Crossref]
- 13. Menown IB, Mackenzie G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J 2000; 21: 275-83. [Crossref]
- 14. Macfarlane PW. Age, sex, and the ST amplitude in health and disease. J Electrocardiol 2001; 34 Suppl: 235-41. [Crossref]
- 15. Wu J, Kors JA, Rijnbeek PR, van Herpen G, Lu Z, Xu C. Normal limits of the electrocardiogram in Chinese subjects. Int J Cardiol 2003; 87: 37-51. [Crossref] 16. Macfarlane PW, Browne D, Devine B, Clark E, Miller E, Seyal J, et al. Modification of ACC/ESC criteria for acute myocardial infarction. J Electrocardiol 2004; 37 Suppl: 98-103. [Crossref]
- 17. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al.; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 2018; 72: 2231-64. [Crossref]
- 18. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al.; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e362-425.
- 19. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al.; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119-77. [Crossref]
- 20. McCabe JM, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, et al. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention-capable centers: a report from the Activate-SF registry. Arch Intern Med 2012; 172: 864-71. [Crossref]
- 21. Larson DM, Menssen KM, Sharkey SW, Duval S, Schwartz RS, Harris J, et al. "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA 2007; 298: 2754-60. [Crossref]
- 22. Kontos MC, Kurz MC, Roberts CS, Joyner SE, Kreisa L, Ornato JP, et al. An evaluation of the accuracy of emergency physician activation of the cardiac catheterization laboratory for patients with suspected ST-segment elevation myocardial infarction. Ann Emerg Med 2010; 55: 423-30. [Crossref]
- 23. Martí D, Mestre JL, Salido L, Esteban MJ, Casas E, Pey J, et al. Incidence, angiographic features and outcomes of patients presenting with subtle ST-elevation myocardial infarction. Am Heart J 2014; 168: 884-90. [Crossref]
- 24. Schmitt C, Lehmann G, Schmieder S, Karch M, Neumann FJ, Schömig A. Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel: limitations of ST-segment elevation in standard and extended ECG leads. Chest 2001; 120: 1540-6. [Crossref]
- 25. Koyama Y, Hansen PS, Hanratty CG, Nelon GI, Rasmussen HH. Prevalence of coronary occlusion and outcome of an immediate invasive strategy in suspected acute myocardial infarction with and without ST-segment elevation. Am J Cardiol 2002; 90: 579-84. [Crossref]
- 26. Abbas AE, Boura JA, Brewington SD, Dixon SR, O'Neill WW, Grines CL. Acute angiographic analysis of non-ST-segment elevation acute myocardial infarction. Am J Cardiol 2004; 94: 907-9. [Crossref]
- 27. Wang TY, Zhang M, Fu Y, Armstrong PW, Newby LK, Gibson CM, et al. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. Am Heart J 2009; 157: 716-23. [Crossref]
- 28. Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, et al.; TIMI Study Group. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. JACC Cardiovasc Interv 2010; 3: 806-11. [Crossref]
- 29. Khan AR, Golwala H, Tripathi A, Bin Abdulhak AA, Bavishi C, Riaz H, et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J 2017; 38: 3082-9. [Crossref] 30. Hillinger P, Strebel I, Abächerli R, Twerenbold R, Wildi K, Bernhard D, et al.; APACE Investigators. Prospective validation of current quantitative electrocardiographic criteria for ST-elevation myocardial infarction. Int J Cardiol 2019; 292: 1-12. [Crossref]
- 31. Mehta SR, Granger CB, Boden WE, Steg PG, Bassand JP, Faxon DP, et al.; TIMACS Investigators. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 2009; 360: 2165-75. [Crossref]
- 32. Hoedemaker NPG, Damman P, Woudstra P, Hirsch A, Windhausen F, Tijssen JGP, et al.; ICTUS Investigators. Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial. J Am Coll Cardiol 2017; 69: 1883-93. [Crossref]
- 33. van 't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, et al. A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromes. Eur Heart J 2003; 24: 1401-5. [Crossref]
- 34. Thiele H, Rach J, Klein N, Pfeiffer D, Hartmann A, Hambrecht R, et al.; LIPSIA-NSTEMI Trial Group. Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J 2012; 33: 2035-43. [Crossref]
- 35. Montalescot G, Cayla G, Collet JP, Elhadad S, Beygui F, Le Breton H, et al.; ABOARD Investigators. Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial. JAMA 2009; 302: 947-54. [Crossref]
- 36. Milosevic A, Vasiljevic-Pokrajcic Z, Milasinovic D, Marinkovic J, Vukcevic V, Stefanovic B, et al. Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients: The RIDDLE-NSTEMI Study. JACC Cardiovasc Interv 2016; 9: 541-9. [Crossref]
- 37. Neumann FJ, Kastrati A, Pogatsa-Murray G, Mehilli J, Bollwein H, Bestehorn HP, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronry syndromes: a randomized controlled trial. JAMA 2003; 290: 1593-9. [Crossref]
- 38. Reuter PG, Rouchy C, Cattan S, Benamer H, Jullien T, Beruben A, et al. Early invasive strategy in high-risk acute coronary syndrome without ST-segment elevation. The Sisca randomized trial. Int J Cardiol 2015; 182: 414-8. [Crossref]
- 39. Aslanger EK, Yıldırımtürk Ö, Şimşek B, Bozbeyoğlu E, Şimşek MA, Yücel Karabay C, et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study). Int J Cardiol Heart Vasc 2020; 30: 100603. [Crossref]
- 40. Meyers HP, Bracey A, Lee D, Lichtenheld A, Li WJ, Singer DD, et al. Comparison of the ST-Elevation Myocardial Infarction (STEMI) vs. NSTEMI and Occlusion MI (OMI) vs. NOMI Paradigms of Acute MI. J Emerg Med 2020: S0736-4679(20)31070-2. [Crossref]
- 41. Miranda DF, Lobo AS, Walsh B, Sandoval Y, Smith SW. New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute Myocardial Infarction in the Emergency Department. Can J Cardiol 2018; 34: 132-45. [Crossref]
- 42. Smith SW, Khalil A, Henry TD, Rosas M, Chang RJ, Heller K, et al. Electrocardiographic differentiation of early repolarization from subtle anterior ST-segment elevation myocardial infarction. Ann Emerg Med 2012; 60: 45-56. [Crossref]
- 43. Aslanger E, Yıldırımtürk Ö, Bozbeyoğlu E, Şimşek B, Karabay CY, Türer Cabbar A, et al. A Simplified Formula Discriminating Subtle Anterior Wall Myocardial Infarction from Normal Variant ST-Segment Elevation. Am J Cardiol 2018; 122: 1303-9. [Crossref]
- 44. Durant E, Singh A. Acute first diagonal artery occlusion: a characteristic pattern of ST elevation in noncontiguous leads. Am J Emerg Med 2015; 33: 1326.e3-5. [Crossref] 45. Aslanger E, Yıldırımtürk Ö, Şimşek B, Sungur A, Türer Cabbar A, Bozbeyoğlu E, et al. A new electrocardiographic pattern indicating inferior myocardial infarction. J Electrocardiol 2020; 61: 41-6. [Crossref]
- 46. Verouden NJ, Koch KT, Peters RJ, Henriques JP, Baan J, van der Schaaf RJ, et al. Persistent precordial "hyperacute" T-waves signify proximal left anterior descending artery occlusion. Heart 2009; 95: 1701-6. [Crossref]
- 47. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006; 333: 1091. [Crossref]
- 48. Eek C, Grenne B, Brunvand H, Aakhus S, Endresen K, Smiseth OA, et al. Strain echocardiography predicts acute coronary occlusion in patients with non-ST-segment elevation acute coronary syndrome. Eur J Echocardiogr 2010; 11: 501-8. [Crossref]
- 49. Rowland-Fisher A, Smith S, Laudenbach A, Reardon R. Diagnosis of acute coronary occlusion in patients with non-STEMI by point-of-care echocardiography with speckle tracking. Am J Emerg Med 2016; 34: 1914.e3-6. [Crossref]
- 50. Linde JJ, Kelbæk H, Hansen TF, Sigvardsen PE, Torp-Pedersen C, Bech J, et al. Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. J Am Coll Cardiol 2020; 75: 453-63. [Crossref]
- 51. Meyers HP, Bracey A, Lee D, Lichtenheld A, Li W, Singer D, et al. Abstract 12682: Accuracy of Expert Electrocardiography versus ST-Segment Elevation Myocardial Infarction Criteria for Diagnosis of Acute Coronary Occlusion Myocardial Infarction. Circulation 2020; 142: A12682
| APA | Aslanger E, Meyers H, Smith S (2021). Time for a new paradigm shift in myocardial infarction. , 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| Chicago | Aslanger Emre,Meyers Harvey,Smith Stephen Time for a new paradigm shift in myocardial infarction. (2021): 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| MLA | Aslanger Emre,Meyers Harvey,Smith Stephen Time for a new paradigm shift in myocardial infarction. , 2021, ss.156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| AMA | Aslanger E,Meyers H,Smith S Time for a new paradigm shift in myocardial infarction. . 2021; 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| Vancouver | Aslanger E,Meyers H,Smith S Time for a new paradigm shift in myocardial infarction. . 2021; 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| IEEE | Aslanger E,Meyers H,Smith S "Time for a new paradigm shift in myocardial infarction." , ss.156 - 162, 2021. 10.5152/AnatolJCardiol.2021.89304 |
| ISNAD | Aslanger, Emre vd. "Time for a new paradigm shift in myocardial infarction". (2021), 156-162. https://doi.org/10.5152/AnatolJCardiol.2021.89304 |
| APA | Aslanger E, Meyers H, Smith S (2021). Time for a new paradigm shift in myocardial infarction. The Anatolian Journal of Cardiology, 25(3), 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| Chicago | Aslanger Emre,Meyers Harvey,Smith Stephen Time for a new paradigm shift in myocardial infarction. The Anatolian Journal of Cardiology 25, no.3 (2021): 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| MLA | Aslanger Emre,Meyers Harvey,Smith Stephen Time for a new paradigm shift in myocardial infarction. The Anatolian Journal of Cardiology, vol.25, no.3, 2021, ss.156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| AMA | Aslanger E,Meyers H,Smith S Time for a new paradigm shift in myocardial infarction. The Anatolian Journal of Cardiology. 2021; 25(3): 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| Vancouver | Aslanger E,Meyers H,Smith S Time for a new paradigm shift in myocardial infarction. The Anatolian Journal of Cardiology. 2021; 25(3): 156 - 162. 10.5152/AnatolJCardiol.2021.89304 |
| IEEE | Aslanger E,Meyers H,Smith S "Time for a new paradigm shift in myocardial infarction." The Anatolian Journal of Cardiology, 25, ss.156 - 162, 2021. 10.5152/AnatolJCardiol.2021.89304 |
| ISNAD | Aslanger, Emre vd. "Time for a new paradigm shift in myocardial infarction". The Anatolian Journal of Cardiology 25/3 (2021), 156-162. https://doi.org/10.5152/AnatolJCardiol.2021.89304 |
